ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04360	Axon guidance	19/90	233/7206	4.33543761502e-11
ko05200	Pathways in cancer	21/90	492/7206	4.3660200672e-07
ko04340	Hedgehog signaling pathway	5/90	58/7206	0.000739349509016
ko05217	Basal cell carcinoma	5/90	68/7206	0.00152529455742
ko00310	Lysine degradation	5/90	73/7206	0.00209311380639
ko04144	Endocytosis	11/90	342/7206	0.00336767605257
ko05212	Pancreatic cancer	5/90	83/7206	0.00367024493068
ko05220	Chronic myeloid leukemia	5/90	85/7206	0.00406650675839
ko05206	MicroRNAs in cancer	7/90	177/7206	0.00645248772042
ko04919	Thyroid hormone signaling pathway	6/90	143/7206	0.00873947606765
ko04390	Hippo signaling pathway	7/90	188/7206	0.00887782032569
ko04350	TGF-beta signaling pathway	5/90	103/7206	0.00911228843395
ko04520	Adherens junction	5/90	103/7206	0.00911228843395
ko04110	Cell cycle	6/90	145/7206	0.00932708398325
ko05166	HTLV-I infection	9/90	292/7206	0.0103484434826
ko05161	Hepatitis B	6/90	173/7206	0.02077394981
ko03015	mRNA surveillance pathway	4/90	93/7206	0.028625915894
ko04151	PI3K-Akt signaling pathway	10/90	390/7206	0.0294471945134
ko05132	Salmonella infection	4/90	98/7206	0.0338059921318
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	2/90	26/7206	0.0412935234832
ko04659	Th17 cell differentiation	4/90	106/7206	0.0431644590707
ko01521	EGFR tyrosine kinase inhibitor resistance	4/90	106/7206	0.0431644590707
ko05215	Prostate cancer	4/90	111/7206	0.0496856036532